Now, For Aspirin's Next Magic Trick
Regular use of aspirin may sharply cut the odds of developing colon cancer, according to a study published in the Dec. 5 New England Journal of Medicine. Based on data from 662,400 people tracked by the American Cancer Society from 1982 to 1988, researchers led by Dr. Michael Thun found that those who took aspirin 16 or more times a month for a year had half the risk of developing fatal colon cancer as nonusers.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.